Viewing Study NCT00593060


Ignite Creation Date: 2025-12-25 @ 2:01 AM
Ignite Modification Date: 2026-01-04 @ 3:53 PM
Study NCT ID: NCT00593060
Status: COMPLETED
Last Update Posted: 2023-05-24
First Post: 2007-12-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal Cancer
Sponsor: Jeffrey W. Clark, MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module